SIMULATION STUDY OF PRECLINICAL DEVELOPMENT OF ANTICANCER DRUGS

被引：0
|
作者：
GORDON, MH [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
来源：
CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT | 1974年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 78
页数：14
相关论文
共 50 条
  • [21] New antifungal drugs in preclinical development
    Hector, RF
    COCCIDIOIDOMYCOSIS: CENTENNIAL CONFERENCE, 1996, : 265 - 274
  • [22] Preclinical study of drugs for osteoarthritis
    Laoussadi, S
    Menkes, CJ
    SEMAINE DES HOPITAUX, 1997, 73 (13-14): : 417 - 424
  • [23] Toxicity testing in the development of anticancer drugs
    Double, J
    Barrass, N
    Barnard, ND
    Navaratnam, V
    LANCET ONCOLOGY, 2002, 3 (07): : 438 - 442
  • [24] Strategy for the development of novel anticancer drugs
    Nagahiro Saijo
    Tomohide Tamura
    Kazuto Nishio
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 97 - 101
  • [25] Strategy for the development of novel anticancer drugs
    Saijo, N
    Tamura, T
    Nishio, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (Suppl 1) : S97 - S101
  • [26] Advances in the development of hybrid anticancer drugs
    Fortin, Sebastien
    Berube, Gervais
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (08) : 1029 - 1047
  • [27] The development of proteasome inhibitors as anticancer drugs
    Adams, J
    CANCER CELL, 2004, 5 (05) : 417 - 421
  • [28] The development of ruthenium complexes as anticancer drugs activation and anticancer mechanism
    Liu, J
    Ji, LN
    Mei, WJ
    PROGRESS IN CHEMISTRY, 2004, 16 (06) : 969 - 974
  • [29] Antiviral drugs specific for coronaviruses in preclinical development
    Adedeji, Adeyemi O.
    Sarafianos, Stefan G.
    CURRENT OPINION IN VIROLOGY, 2014, 8 : 45 - 53
  • [30] Preclinical development of cancer stem cell drugs
    Zhou, Jiangbing
    Zhang, Ying
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (07) : 741 - 752
12345